Advanced Search

Universal Flu Vaccine Stocks List

Symbol Grade Name % Change
INO D Inovio Pharmaceuticals, Inc. -2.61
BVXV F BiondVax Pharmaceuticals Ltd. -2.89
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Influenza Influenza Vaccine Medicine Vaccination Vaccine Avian Influenza Biopharmaceutical Cancers Cervical Cancer Clinical Research Coronavirus Drugs Electroporation Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Human Influenza Immunodeficiency Infectious Diseases

Related ETFs - A few ETFs which own one or more of the above listed Universal Flu Vaccine stocks.

Symbol Grade Name Weight
GERM C ETFMG Treatments Testing and Advancements ETF 2.39
IDNA D iShares Genomics Immunology and Healthcare ETF 1.57
MOON C Direxion Moonshot Innovators ETF 1.55
XBI D SPDR Series Trust SPDR S&P Biotech ETF 0.76
IBBJ D Defiance Nasdaq Junior Biotechnology ETF 0.62
View all Universal Flu Vaccine related ETFs...
Compare ETFs
  • Compare GERM to IDNA
  • Compare MOON to IBBJ
  • Compare MOON to XBI

    • Recent Signals

    Date Stock Signal Type
    2021-02-25 BVXV Fell Below 50 DMA Bearish
    2021-02-25 BVXV New Downtrend Bearish
    2021-02-25 BVXV Stochastic Reached Oversold Weakness
    2021-02-25 BVXV MACD Bearish Centerline Cross Bearish

    Recent News for Universal Flu Vaccine Stocks

    Date Stock Title
    Feb 25 INO A Balanced Take on Inovio Pharmaceuticals Stock
    Feb 24 INO Qiagen to develop a companion diagnostic for Inovio’s VGX-3100 in cervical dysplasia
    Feb 24 INO The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
    Feb 24 INO Qiagen, Inovio In Development Pact For VGX-3100 Companion Diagnostics
    Feb 24 INO QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO’s VGX-3100 for Advanced Cervical Dysplasia
    Feb 24 INO INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia
    Feb 23 INO INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa
    Feb 21 INO Are Short-Sellers Right About Inovio?
    Related Industries: Biotechnology
    Related Stock Lists: Influenza Influenza Vaccine Medicine Vaccination Vaccine Avian Influenza Biopharmaceutical Cancers Cervical Cancer Clinical Research Coronavirus Drugs Electroporation Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Human Influenza Immunodeficiency Infectious Diseases

    Browse All Tags